Skip to main content
SpringerLink
Log in

Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections

  • Articles
  • Ciprofloxacin: Clinical Experience
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

The therapeutic efficacy and safety of ciprofloxacin was studied in 30 patients withPseudomonas aeruginosa infections. In 20 patients ciprofloxacin was given alone and in 10 patients (including 8 compromized hosts) in combination with an aminoglycoside (9) or azlocillin (1). Ciprofloxacin was given in doses of 500 mg orally or 200–300 mg i. v. every 12 h. In patients receiving only ciprofloxacin clinical cure with eradication of bacteria was obtained in 15 patients (75%) with infections of bone and joint (6), skin and soft tissue (4), lung (2), middle ear (2) and CSF (1). Two patients with lymphoma andPseudomonas aeruginosa pneumonia died. In patients receiving combination therapy a definite therapeutic success was achieved in four (40%). Three patients withPseudomonas aeruginosa septicemia died. In seven patients nine bacterial strains with decreasing susceptibility of ciprofloxacin (increase in MIC from ⩽0.5μg/ml to 2–16 μg/ml) were selected (6Pseudomonas aeruginosa, 1Enterobacter cloacae, 1Serratia marcescens, 1Staphylococcus aureus). Ciprofloxacin was well tolerated. This new quinolone seems to be suitable for single drug treatment ofPseudomonas aeruginosa infections in patients with normal host defense mechanisms, while its therapeutic potential in compromized hosts requires further evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Muytjens, H. L., van der Ros-van de Repe, J., Veldhuizen, G.: Comparative eactivities of ciprofloxacin (Bay 09867), norfloxacin, pipemidic acid, and nalidixic acid. Antimicrobial Agents and Chemotherapy 1983, 24: 302–304.

    PubMed  CAS  Google Scholar 

  2. Chin, N. X., Neu, H. C.: Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1984, 25: 319–326.

    PubMed  CAS  Google Scholar 

  3. Reeves, D. S., Bywater, M. J., Holt, H. A., White, L. O.: In vitro studies with ciprofloxacin, a new 4-quinolone compound. Journal of Antimicrobial Chemotherapy 1984, 13: 333–346.

    PubMed  CAS  Google Scholar 

  4. Van Caekenberghe, D. L., Pattyn, S. R.: In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives. Antimicrobial Agents and Chemotherapy 1984, 25: 518–521.

    PubMed  Google Scholar 

  5. Schiff, J. B., Small, G. J., Pennington, J. E.: Comparative activities of ciprofloxacin, ticarcillin and tobramycin against experimentalPseudomonas aeruginosa pneumonia. Antimicrobial Agents and Chemotherapy 1984, 24: 1–4.

    Google Scholar 

  6. Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissues penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 784–786.

    PubMed  CAS  Google Scholar 

  7. Wingender, W., Graefe, K. H., Gau, W., Förster, D., Beermann, D., Schacht, P.: Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers. European Journal of Clinical Microbiology 1984, 3: 355–359.

    Article  PubMed  CAS  Google Scholar 

  8. Aronoff, G. E., Kenner, C. H., Sloan, R. S., Pottratz, S. T.: Multiple-dose ciprofloxacin kinetics in normal subjects. Clinical Pharmacology and Therapeutics 1984, 36: 384–388.

    Article  PubMed  CAS  Google Scholar 

  9. Gau, W., Ploschke, H. J., Schmidt, K., Weber, B.: Determination of ciprofloxacin (BAY O 9867) in biological fluids by high-performance liquid chromatography. Journal of Liquid Chromatography 1985, 8: 485–497.

    CAS  Google Scholar 

  10. Eron, L. J., Harvey, L., Hixon, D. L., Poretz, D. M.: Ciprofloxacin therapy of infections caused byPseudomonas aeruginosa and other resistant bacteria. Antimicrobial Agents and Chemotherapy 1985, 28: 308–310.

    PubMed  CAS  Google Scholar 

  11. Brumfitt, W., Franklin, I., Grady, D., Hamilton-Miller, J. M. T., Iliffe, A.: Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrobial Agents and Chemotherapy, 1984, 26: 757–761.

    PubMed  CAS  Google Scholar 

  12. Gonzales, M. A., Uribe, F., Moisen, S. D., Fuster, P. A., Selen, A., Welling, P. G., Painter, B.: Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 741–744.

    PubMed  Google Scholar 

  13. Sanders, C. C., Sanders, W. E., Goering, R. V., Werner, V.: Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrobial Agents and Chemotherapy 1984, 26: 797–801.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Department of Medicine, University Hospital, 4031, Basel, Switzerland

    F. Follath, M. Bindschedler & M. Wenk

  2. Microbiological Laboratory, University Hospital, 4031, Basel, Switzerland

    R. Frei & H. Reber

  3. Medical Clinic, Cantonal Hospital, 4410, Liestal, Switzerland

    H. Stalder

Authors
  1. F. Follath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Bindschedler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Wenk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Frei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Stalder
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Reber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Follath, F., Bindschedler, M., Wenk, M. et al. Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infections. Eur. J, Clin. Microbiol. 5, 236–240 (1986). https://doi.org/10.1007/BF02013997

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013997

Keywords

Search

Navigation